Donald Bergstrom, M.D., Ph.D., is a distinguished leader in the field of pharmaceutical research and development, currently serving as President, Research & Development at RELAY THERAPEUTICS INC. Dr. Bergstrom brings a wealth of experience and expertise to his role, having earned both his medical degree and doctorate from prestigious institutions. His dual training in medicine and science has equipped him with a unique perspective that allows him to drive innovative drug discovery and development initiatives at Relay Therapeutics. Throughout his career, Dr. Bergstrom has held several key leadership positions in the biopharmaceutical industry, where he has been instrumental in advancing novel therapies from concept to clinical application. His notable achievements include spearheading the development of groundbreaking treatments for various diseases, particularly in the areas of oncology and immunology. Dr. Bergstrom's strategic vision and commitment to scientific excellence have been pivotal in his success, earning him recognition as a thought leader in the field. At RELAY THERAPEUTICS INC., Dr. Bergstrom oversees the company's research and development efforts, guiding the team in their mission to develop transformative medicines for patients with unmet medical needs. His leadership is characterized by a collaborative approach, fostering a culture of innovation and scientific rigor within the organization. Under his guidance, Relay Therapeutics continues to push the boundaries of drug discovery, leveraging cutting-edge technologies to accelerate the development of life-changing therapies.